Scarica l'app Stockscreener
28.73
0.55%
-0.1584
Roundhill Glp 1 Weight Loss Etf Borsa (OZEM) Ultime notizie
From Laggard to Leader: The Surprising Comeback of Healthcare - ETF Database
Lilly vs. Novo: Inside the Milan EASD Showdown and the ETFs Poised to Win - The Globe and Mail
Lilly vs. Novo: Inside the Milan EASD Showdown and the ETFs Poised to Win - The Globe and Mail
Lilly vs. Novo: Inside the Milan EASD Showdown and the ETFs Poised to Win - Zacks Investment Research
Lilly vs. Novo: Inside the Milan EASD Showdown and the ETFs Poised to Win - TradingView
5 Best GLP-1 Stocks for 2026 and How to Invest - The Motley Fool
OZEM Top Holdings List & Exposure (Roundhill GLP-1 & Weight Loss ETF) - marketbeat.com
Precision Trading with Roundhill Etf Trust Glp-1 & Weight Loss Etf (OZEM) Risk Zones - Stock Traders Daily
How to Buy Novo Nordisk Stock (NVO): Step-by-Step & What to Expect - The Motley Fool
Pfizer Inc (PFE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
AstraZeneca PLC (AZN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Scholar Rock Holding Corp (SRRK) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Structure Therapeutics Inc (GPCR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Rhythm Pharmaceuticals Inc (RYTM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Viking Therapeutics Inc (VKTX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Novo Nordisk A/S (NVO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Eli Lilly and Co (LLY) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
OZEM Dividend: 1.26% Yield, $0.41/Share — History & Dates - GuruFocus
OZEM ETF Profile: Dividends, Returns (BOATS:OZEM) - TradingView
OZEM ETF Profile: Dividends, Returns (NASDAQ:OZEM) - TradingView
OZEM ETF Profile: Dividends, Returns (CFI:OZEM) - TradingView
OZEM Archives - 24/7 Wall St.
OZEM Archives - 24/7 Wall St.
Weight Loss ETFs Poised to Rally as Medicare Greenlights GLP-1 Coverage - The Globe and Mail
Weight Loss ETFs Poised to Rally as Medicare Greenlights GLP-1 Coverage - The Globe and Mail
Weight Loss ETFs Poised to Rally as Medicare Greenlights GLP-1 Coverage - Eastern Progress
3 Non-Pharma Firms That Could Benefit From the GLP-1 Trend - The Globe and Mail
3 Non-Pharma Firms That Could Benefit From the GLP-1 Trend - The Globe and Mail
Rhythm Pharmaceuticals Inc (RYTM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Novo Nordisk A/S (NVO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Scholar Rock Holding Corp (SRRK) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Biohaven Ltd (BHVN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Metsera Inc (MTSR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Viking Therapeutics Inc (VKTX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Structure Therapeutics Inc (GPCR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Eli Lilly and Co (LLY) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
AstraZeneca PLC (AZN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Terns Pharmaceuticals Inc (TERN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Pfizer Inc (PFE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Healthcare ETFs: From Broad Exposure to Big Breakthroughs - etftrends.com
Inside the GLP-1 Boom: ETF Picks for the Obesity Drug Market - The Globe and Mail
Inside the GLP-1 Boom: ETF Picks for the Obesity Drug Market - TradingView
Inside the GLP-1 Boom: ETF Picks for the Obesity Drug Market - The Globe and Mail
TD Cowen Raises GLP-1 Sales Forecast To $150B By 2030 – Industry Leaders LLY, NVO To Remain Dominant - TradingView
TD Cowen Raises GLP-1 Sales Forecast To $150B By 2030 – Industry Leaders LLY, NVO To Remain Dominant - TradingView
GLP-1 Drug Giants Race to Go Global With Their Obesity Pills: ETFs to Gain - The Globe and Mail
GLP-1 Drug Giants Race to Go Global With Their Obesity Pills: ETFs to Gain - TradingView
GLP-1 Drug Giants Race to Go Global With Their Obesity Pills: ETFs to Gain - Eastern Progress
GLP-1 Drug Giants Race to Go Global With Their Obesity Pills: ETFs to Gain - The Globe and Mail
485BPOS: Post-effective amendment - Moomoo
0.71%
0.04%
Capitalizzazione:
|
Volume (24 ore):